ACUTE SPINAL CORD INJURY (SCI)
Clinical trials for ACUTE SPINAL CORD INJURY (SCI) explained in plain language.
Never miss a new study
Get alerted when new ACUTE SPINAL CORD INJURY (SCI) trials appear
Sign up with your email to follow new studies for ACUTE SPINAL CORD INJURY (SCI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a migraine pill help heal spinal cord injuries?
Disease control Recruiting nowThis study tests a drug called TZ-161 (Eletriptan hydrobromide), originally used for migraines, in people with recent spinal cord injury. The goal is to see if it is safe and can help improve recovery. About 28 adults aged 18-65 with a thoracic spinal injury will receive the drug…
Matched conditions: ACUTE SPINAL CORD INJURY (SCI)
Phase: PHASE1, PHASE2 • Sponsor: Technophage, SA • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for spinal cord injury: early access to investigational drug
Disease control AVAILABLEThis program offers early access to elezanumab, an investigational drug, for people with acute spinal cord injury who have no other suitable treatment options and cannot join ongoing clinical trials. A doctor must decide if the potential benefit outweighs the risks. The drug is n…
Matched conditions: ACUTE SPINAL CORD INJURY (SCI)
Sponsor: AbbVie • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
Shock to the system: early electrical zaps may boost recovery after spinal injury
Symptom relief Recruiting nowThis study tests whether applying mild electrical stimulation to the skin over the spine, starting just 3 days after a spinal cord injury, is safe and might help patients regain movement. Researchers will monitor 15 participants for side effects and measure changes in muscle stre…
Matched conditions: ACUTE SPINAL CORD INJURY (SCI)
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC